Heidi C.  Chen net worth and biography

Heidi Chen Biography and Net Worth

EVP of Zoetis
Heidi C. Chen serves as Executive Vice President, General Counsel, Corporate Secretary of Zoetis Inc. Ms. Chen has served as our Executive Vice President and General Counsel since October 2012, and as our Corporate Secretary since July 2012. Ms. Chen was also given responsibility for our Human Health Diagnostics business in January 2020. Prior to Zoetis, Ms. Chen was Vice President and Chief Counsel of Pfizer Animal Health, our predecessor company, from 2009 to 2012. Ms. Chen joined Pfizer in 1998 and held various legal and compliance positions of increasing responsibility, including lead counsel for Pfizer’s Established Products (generics) business.

What is Heidi C. Chen's net worth?

The estimated net worth of Heidi C. Chen is at least $4.78 million as of September 15th, 2023. Ms. Chen owns 27,478 shares of Zoetis stock worth more than $4,780,622 as of October 1st. This net worth approximation does not reflect any other investments that Ms. Chen may own. Additionally, Ms. Chen receives a salary of $1,040,000.00 as EVP at Zoetis. Learn More about Heidi C. Chen's net worth.

How old is Heidi C. Chen?

Ms. Chen is currently 56 years old. There are 6 older executives and no younger executives at Zoetis. The oldest executive at Zoetis is Ms. Roxanne Lagano, Exec. VP and Chief HR Officer & Global Operations, who is 58 years old. Learn More on Heidi C. Chen's age.

What is Heidi C. Chen's salary?

As the EVP of Zoetis Inc., Ms. Chen earns $1,040,000.00 per year. There are 3 executives that earn more than Ms. Chen. The highest earning executive at Zoetis is Ms. Kristin C. Peck, CEO & Director, who commands a salary of $2,800,000.00 per year. Learn More on Heidi C. Chen's salary.

How do I contact Heidi C. Chen?

The corporate mailing address for Ms. Chen and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Heidi C. Chen's contact information.

Has Heidi C. Chen been buying or selling shares of Zoetis?

Heidi C. Chen has not been actively trading shares of Zoetis during the last ninety days. Most recently, Heidi C. Chen sold 9,905 shares of the business's stock in a transaction on Friday, September 15th. The shares were sold at an average price of $180.15, for a transaction totalling $1,784,385.75. Following the completion of the sale, the executive vice president now directly owns 27,478 shares of the company's stock, valued at $4,950,161.70. Learn More on Heidi C. Chen's trading history.

Who are Zoetis' active insiders?

Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.

Are insiders buying or selling shares of Zoetis?

In the last twelve months, insiders at the sold shares 6 times. They sold a total of 30,268 shares worth more than $5,455,026.38. The most recent insider tranaction occured on September, 18th when EVP Roxanne Lagano sold 923 shares worth more than $165,752.34. Insiders at Zoetis own 0.1% of the company. Learn More about insider trades at Zoetis.

Information on this page was last updated on 9/18/2023.

Heidi C. Chen Insider Trading History at Zoetis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2023Sell9,905$180.15$1,784,385.7527,478View SEC Filing Icon  
11/9/2021Sell9,446$220.00$2,078,120.00View SEC Filing Icon  
10/25/2021Sell9,446$210.22$1,985,738.12View SEC Filing Icon  
4/21/2021Sell11,637$170.14$1,979,919.1836,282View SEC Filing Icon  
12/1/2020Sell1,180$161.64$190,735.2017,515View SEC Filing Icon  
11/2/2020Sell1,179$161.43$190,325.9717,514View SEC Filing Icon  
10/1/2020Sell1,179$166.23$195,985.1717,514View SEC Filing Icon  
9/1/2020Sell1,179$160.71$189,477.0917,514View SEC Filing Icon  
8/3/2020Sell1,179$152.19$179,432.0117,514View SEC Filing Icon  
7/1/2020Sell1,179$137.29$161,864.9117,514View SEC Filing Icon  
6/1/2020Sell1,179$138.65$163,468.3517,514View SEC Filing Icon  
5/1/2020Sell1,179$127.44$150,251.7617,514View SEC Filing Icon  
2/3/2020Sell1,179$134.58$158,669.8212,642View SEC Filing Icon  
1/21/2020Sell15,329$139.81$2,143,147.4926,792View SEC Filing Icon  
6/3/2019Sell2,500$104.23$260,575.0011,463View SEC Filing Icon  
3/12/2019Sell15,710$95.49$1,500,147.9013,963View SEC Filing Icon  
12/3/2018Sell2,500$93.51$233,775.0017,662View SEC Filing Icon  
3/16/2018Sell7,383$84.71$625,413.9320,162View SEC Filing Icon  
2/20/2018Sell37,453$81.02$3,034,442.06View SEC Filing Icon  
9/1/2016Sell32,097$50.98$1,636,305.0646,060View SEC Filing Icon  
See Full Table

Heidi C. Chen Buying and Selling Activity at Zoetis

This chart shows Heidi C Chen's buying and selling at Zoetis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zoetis Company Overview

Zoetis logo
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Read More

Today's Range

Now: $173.98
Low: $173.79
High: $175.59

50 Day Range

MA: $184.66
Low: $173.95
High: $192.77

2 Week Range

Now: $173.98
Low: $124.15
High: $194.99


1,498,511 shs

Average Volume

1,475,564 shs

Market Capitalization

$80.09 billion

P/E Ratio


Dividend Yield